Status:
TERMINATED
Therapeutic Education Consultations With Diabetic Patients Treated With Intensified Insulin Therapy
Lead Sponsor:
Hopital Nord Franche-Comte
Conditions:
Diabete Mellitus
Insulin Dependent Diabetes
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
Diabetes is a chronic condition that affects around 8% of the French population, and is associated with severe complications. Maintaining a constant blood glucose level of between 0.7 and 1.80 g/l is ...
Eligibility Criteria
Inclusion
- Woman or man aged 18 to 75
- Diabetic patient type 1 or 2 insulin-dependent
- Patient treated with multi-injections or insulin pump
- Patient equipped with FreeStyle Libre flash glucose monitoring system
- Glycemic imbalance with HBA1c \> 8
- Patient living at home
Exclusion
- Recent discovery (\< 6 months) of diabetes
- Major intellectual disability
- Social isolation
- IMC \> 35
- Pregnant women
Key Trial Info
Start Date :
February 9 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2025
Estimated Enrollment :
7 Patients enrolled
Trial Details
Trial ID
NCT06167499
Start Date
February 9 2024
End Date
March 1 2025
Last Update
August 8 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hôpital Nord Franche-Comté
Trévenans, France